Delay of M-phase onset by aphidicolin can retain the nuclear localization of zinc and metallothionein in 3T3-L1 fibroblasts

• Published in: Journal of cellular physiology 2000-05, Vol.183 (2), p.247-253
• Main Authors: Apostolova, Margarita D., Cherian, M. George
• Format: Article
• Language: English
• Subjects: 3T3 Cells; Animals; Aphidicolin - pharmacology; Biological Transport, Active; Cell Cycle; Cell Differentiation; Cell Nucleus - metabolism; Cytoplasm - metabolism; DNA - biosynthesis; Metallothionein - metabolism; Mice; Mitosis - drug effects; Nucleic Acid Synthesis Inhibitors - pharmacology; Zinc - metabolism
• ISSN: 0021-9541; 1097-4652
• DOI: 10.1002/(SICI)1097-4652(200005)183:2<247::AID-JCP11>3.0.CO;2-X

The transient nuclear localization of metallothionein during cell growth and differentiation may be related to the increased requirement of zinc for DNA synthesis, activation of metalloenzymes, and transcription factors. Treatment of 3T3‐L1 fibroblasts with aphidicolin, an inhibitor of nuclear DNA synthesis, caused a cell‐cycle block at G1/S phase and a delay in the onset of M phase. This also resulted in the accumulation of both zinc and metallothionein in the nucleus. After removal of aphidicolin, the cells rapidly reentered S phase, and during the G2/M phase of cell cycle both zinc and metallothionein began to relocate to the cytoplasm. Delaying the onset of M phase in 3T3‐L1 cells could prevent the cytoplasmic relocation of metallothionein. The nuclear translocation of both zinc and metallothionein during the cell cycle can be considered as a normal process and this may be a general mechanism in response to mitogenic signals. J. Cell. Physiol. 183:247–253, 2000. © 2000 Wiley‐Liss, Inc.